In-silico therapeutic investigations of arjunic acid and arjungenin as an FXR agonist and validation in 3T3-L1 adipocytes

Autor: T, Mohan Manu, T, Anand *, P, Bhuvanesh Kumar, Fathima, Asra, Khanum, Farhath
Zdroj: In Computational Biology and Chemistry February 2020 84
Databáze: ScienceDirect